STOCK TITAN
  1. Home
  2. Financials
  3. NIMU

Non Invasive Financials

NIMU
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE July

This page shows Non Invasive (NIMU) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NIMU FY2025

Balance-sheet erosion has left the company operating with minimal asset backing while unpaid obligations continued to accumulate.

By FY2025, current resources collapsed to $6K against $995K of current liabilities. Compared with FY2023's 0.6x current ratio, that leaves the company operating with an extremely thin liquidity cushion rather than a normal working-capital buffer.

FY2024's reported loss narrowed to -$113K from -$199K in FY2023. Cash conversion worsened because operating cash flow was -$182K in FY2024 versus -$158K a year earlier, so the cash drain deepened even as the income statement looked less negative.

Cash stayed near $89K in FY2022 and $146K in FY2023 because external financing filled much of the operating shortfall. Both years included $150K of financing inflow, and when that support disappeared in FY2024 cash fell to $15K, showing the business had not become self-funding.

Generated by Rhea from SEC filings [ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 0 / 100
Financial Profile 0/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Non Invasive's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage
0

Non Invasive has elevated debt relative to equity (D/E of -1.01), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity
0

Non Invasive's current ratio of 0.01 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
N/A
EPS (Diluted)
$0.00

Non Invasive earned $0.00 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$6K
YoY-60.0%
5Y CAGR-46.7%
10Y CAGR-24.1%

Non Invasive held $6K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
155M
YoY+0.0%
5Y CAGR+0.0%
10Y CAGR+7.0%

Non Invasive had 155M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

NIMU Income Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A $25K N/A $23K-11.5% $26K-58.7% $63K N/A
Operating Income N/A N/A -$25K N/A -$23K+11.5% -$26K+58.7% -$63K N/A
Interest Expense $19K N/A $17K N/A $16K0.0% $16K+14.3% $14K N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A N/A N/A N/A -$39K+7.1% -$42K+45.5% -$77K N/A
EPS (Diluted) $0.00 N/A $0.00 N/A $0.00 $0.00 $0.00 N/A

NIMU Balance Sheet

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Total Assets $26K+333.3% $6K0.0% $6K-14.3% $7K-72.0% $25K-41.9% $43K+13.2% $38K+11.8% $34K
Current Assets $26K+333.3% $6K0.0% $6K-14.3% $7K-72.0% $25K-41.9% $43K+13.2% $38K+11.8% $34K
Cash & Equivalents $24K+300.0% $6K0.0% $6K+100.0% $3K-81.3% $16K+45.5% $11K-26.7% $15K-40.0% $25K
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $1.2M+18.3% $1.0M+0.7% $995K+4.3% $954K+7.2% $890K+2.4% $869K+3.5% $840K+10.7% $759K
Current Liabilities $1.2M+18.3% $1.0M+0.7% $995K+4.3% $954K+4.7% $911K+2.7% $887K+5.6% $840K+421.7% $161K
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$1.2M-16.4% -$996K-0.7% -$989K-4.4% -$947K-9.5% -$865K-4.7% -$826K-3.0% -$802K-10.6% -$725K
Retained Earnings -$29.3M-0.6% -$29.1M0.0% -$29.1M-0.1% -$29.1M-0.2% -$29.0M-0.1% -$29.0M-0.1% -$28.9M-0.3% -$28.8M

NIMU Cash Flow Statement

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Operating Cash Flow -$82K $0+100.0% -$22K-69.2% -$13K+45.8% -$24K-500.0% -$4K+93.8% -$65K-66.7% -$39K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow $100K $0-100.0% $25K $0-100.0% $40K $0-100.0% $55K $0
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

NIMU Financial Ratios

Metric Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A -156.0%-58.3pp -97.7%+105.0pp -202.6% N/A
Current Ratio 0.02+0.0 0.010.0 0.010.0 0.01-0.0 0.03-0.0 0.050.0 0.05-0.2 0.21
Debt-to-Equity N/A -1.010.0 -1.010.0 -1.01+0.0 -1.03+0.0 -1.050.0 -1.050.0 -1.05
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$989K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Non Invasive (NIMU) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Non Invasive (NIMU) had $6K in total assets as of fiscal year 2025, including both current and long-term assets.

Non Invasive (NIMU) had 155M shares outstanding as of fiscal year 2025.

Non Invasive (NIMU) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Non Invasive (NIMU) had a debt-to-equity ratio of -1.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Non Invasive (NIMU) has negative shareholder equity of -$989K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Non Invasive (NIMU) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top